References
- Ayele, B. T., Lipkovich, I., Molenberghs, G., and Mallinckrodt, C. H. (2014), “A Multiple Imputation Based Approach to Sensitivity Analysis and Effectiveness Assessments in Longitudinal Clinical Trials,” Journal of Biopharmaceutical Statistics, 24, 211–228. DOI: https://doi.org/10.1080/10543406.2013.859148.
- Carpenter, J. R., Roger, J. H., Cro, S., and Kenward, M. G. (2014), “Response to Comments by Seaman et al. on ‘Analysis of Longitudinal Trials With Protocol Deviation: A Framework for Relevant, Accessible Assumptions and Inference via Multiple Imputation’,” Journal of Biopharmaceutical Statistics, 24, 1363–1369. DOI: https://doi.org/10.1080/10543406.2014.960085.
- Carpenter, J. R., Roger, J. H., and Kenward, M. G. (2013), “Analysis of Longitudinal Trials With Protocol Deviation: A Framework for Relevant, Accessible Assumptions, and Inference via Multiple Imputation,” Journal of Biopharmaceutical Statistics, 23, 1352–1371. DOI: https://doi.org/10.1080/10543406.2013.834911.
- Cro, S., Carpenter, J. R., and Kenward, M. (2019), “Information-Anchored Sensitivity Analysis: Theory and Application,” Journal of Royal Statistical Society, Series A, 182, 623–645. DOI: https://doi.org/10.1111/rssa.12423.
- Daniels, M. H., and Hogan, J. W. (2008), Missing Data in Longitudinal Studies: Strategies for Bayesian Modeling and Sensitivity Analysis, Boca Raton, FL: Chapman & Hall/CRC.
- ICH (2020), “ICH E9 (R1) Addendum on Estimands and Sensitivity Analysis in Clinical Trials to the Guideline on Statistical Principles for Clinical Trials,” EMA/CHMP/ICH/436221/2017, available at https://www.ema.europa.eu/en/documents/scientific-guideline/ich-e9-r1-addendum-estimands-sensitivity-analysis-clinical-trials-guideline-statistical-principles_en.pdf.
- Little, R., and Yau, L. (1996), “Intent-to-Treat Analysis for Longitudinal Studies With Drop-Outs,” Biometrics, 52, 1324–1333. DOI: https://doi.org/10.2307/2532847.
- Liu, G. F., and Pang, L. (2016), “On Analysis of Longitudinal Clinical Trials With Missing Data Using Reference-Based Imputation,” Journal of Biopharmaceutical Statistics, 26, 924–936. DOI: https://doi.org/10.1080/10543406.2015.1094810.
- Liu, G. F., and Pang, L. (2017), “Control-Based Imputation and Delta-Adjustment Stress Test for Missing Data Analysis in Longitudinal Clinical Trials,” Statistics in Biopharmaceutical Research, 9, 186–194.
- Lu, K. (2014a), “An Analytic Method for the Placebo-Based Pattern-Mixture Model,” Statistics in Medicine, 33, 1134–1145. DOI: https://doi.org/10.1002/sim.6008.
- Lu, K. (2014b), “An Extension of the Placebo-Based Pattern-Mixture Model,” Pharmaceutical Statistics, 13, 103–109.
- Mallinckrodt, C. H., Bell, J., Liu, G., Ratitch, B., O’Kelly, M., Lipkovich, I., Singh, P., Xu, L., and Molenberghs, G. (2020), “Aligning Estimators With Estimands in Clinical Trials: Putting the ICH E9(R1) Guidelines Into Practice,” Therapeutic Innovation & Regulatory Science, 54, 353–364. DOI: https://doi.org/10.1007/s43441-019-00063-9.
- Mallinckrodt, C. H., Lane, P. W., Schnell, D., and Peng, Y. (2008), “Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials,” Drug Information Journal, 42, 303–319. DOI: https://doi.org/10.1177/009286150804200402.
- Mallinckrodt, C. H., Lin, Q., Lipkovich, I., and Molenberghs, G. (2012), “A Structured Approach to Choosing Estimands and Estimators in Longitudinal Clinical Trials,” Pharmaceutical Statistics, 11, 456–461. DOI: https://doi.org/10.1002/pst.1536.
- Mallinckrodt, C. H., Lin, Q., and Molenberghs, G. (2013), “A Structured Framework for Assessing Sensitivity to Missing Data Assumptions in Longitudinal Clinical Trials,” Pharmaceutical Statistics, 12, 1–6. DOI: https://doi.org/10.1002/pst.1547.
- Mallinckrodt, C. H., Roger, J. H., Chuang-Stein, C., Molenberghs, G., Lane, P. W., O’Kelly, M., Ratitch, B., Xu, L., Gilbert, S., Mehrotra, D. V., and Wolfinger, R. (2013), “Missing Data: Turning Guidance Into Action,” Statistics in Biopharmaceutical Research, 5, 369–382. DOI: https://doi.org/10.1080/19466315.2013.848822.
- Meng, X. L. (1994), “Multiple-Imputation Inference With Uncongenial Sources of Input,” Statistical Science, 9, 538–573. DOI: https://doi.org/10.1214/ss/1177010269.
- Morris, T. P., White, I. R., and Crowther, M. J. (2019), “Using Simulation Studies to Evaluate Statistical Methods,” Statistics in Medicine, 38, 2074–2102. DOI: https://doi.org/10.1002/sim.8086.
- Ratitch, B., and O’Kelly M. (2011), “Implementation of Pattern-Mixture Models Using Standard SAS/STAT Procedures,” in Proceedings of PharmaSUG 2011, Paper SP04.
- Ratitch, B., O’Kelly, M., and Tosiello, R. (2013), “Missing Data in Clinical Trials: From Clinical Assumptions to Statistical Analysis Using Pattern Mixture Models,” Pharmaceutical Statistics, 12, 337–347. DOI: https://doi.org/10.1002/pst.1549.
- Rubin, D. (1987), Multiple Imputation for Nonresponse in Surveys, New York: Wiley.
- Seaman, S. R., White, I. R., and Leacy, F. P. (2014), “Comment on ‘Analysis of Longitudinal Trials With Protocol Deviations: A Framework for Relevant, Accessible Assumptions, and Inference via Multiple Imputation’,” Journal of Biopharmaceutical Statistics, 24, 1358–1362. DOI: https://doi.org/10.1080/10543406.2014.928306.
- Siddiqui, O., Hung, J. H. M., and O’Neill, R. (2009), “MMRM Vs. LOCF: A Comprehensive Comparison Based on Simulation Study and 25 NDA Datasets,” Journal of Biopharmaceutical Statistics, 19, 227–246. DOI: https://doi.org/10.1080/10543400802609797.
- Tang, Y. (2017), “On the Multiple Imputation Variance Estimator for Control-Based and Delta-Adjusted Pattern Mixture Models,” Biometrics, 73, 1379–1387. DOI: https://doi.org/10.1111/biom.12702.
- Wang, C., and Daniels, M. (2011), “A Note on MAR, Identifying Restrictions, and Sensitivity Analysis in Pattern Mixture Models With and Without Covariates for Incomplete Data,” Biometrics, 67, 810–818. DOI: https://doi.org/10.1111/j.1541-0420.2011.01565.x.